Contact Us     Search

Understanding potential clinical application for Maltron products

Measurements of Total Body Water do provide us with important information regarding change in Body Composition during growth, ageing and disease. Nevertheless, detailed information can only be obtained when measuring Fat Free Mass hydration that is in Intra and Extracellular ratios.

Extracellular Water (ECW) increases in different diseases and oedema is often the most common sign of ECW expansion. Although these changes in fluid compartments have a clinical significance, no methods have been put in place to detect and monitor these changes. More over, Intracellular Water (ICW) also changes especially in early stages of, for example, heart failure, liver cirrhosis and chronic renal failure.

ECW and ICW change plays an important role in patients with medical conditions. Body composition assessment have been performed in several clinical areas using BioScan on patients with fluid retention, malnutrition, Diabetes, eating disorders, Obesity, estimating Dry weight, Surgery and in Cardiovascular patients. Other are of application are Gastroenterology, HIV, Paediatrics, Endocrine and metabolic disorders, Cystic Fibrosis, during pregnancy and on the elderly as well as many others. What is known, is that the distribution of fluid that is Intracellular and Extracellular ratios change in the different states of diseased patients

Monitoring Nutrition, Intracellular & Extracellular Body Fluids in both healthy and diseased patients is of significant importance. Body composition measurements, including fat and regional fat distribution is important in cardiopulmonary diseased patients such as chronic heart failure, pulmonary disease, chronic obstructive pulmonary disease and cystic fibrosis tend to lose body weight and lean body tissues because of muscle wasting and depletion of bone mineral. Monitoring Body composition in this group of clients enables clinicians to provide nutritional support to encounter these disease effects.

At the other extreme Coronary artery disease (CAD) patents tend to be overweight or obese. Heart lung transplants patients taking immunosuppressant drugs after surgery, typically gain weight due to an increase in FM.  Obesity has been identified as a risk factor which is associated with not only CAD but also related diseases like hypertension and many others.

BioScan is  non invasive and inexpensive methods for measuring body composition of cardiopulmonary patients in clinical setting is required.